Natixis Advisors L.P. Purchases 55,243 Shares of Smith & Nephew plc (NYSE:SNN)

Natixis Advisors L.P. boosted its holdings in shares of Smith & Nephew plc (NYSE:SNN - Free Report) by 332.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 71,879 shares of the medical equipment provider's stock after buying an additional 55,243 shares during the quarter. Natixis Advisors L.P.'s holdings in Smith & Nephew were worth $1,960,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. CWM LLC grew its position in Smith & Nephew by 68.6% in the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 388 shares during the last quarter. Argonautica Private Wealth Management Inc. increased its stake in Smith & Nephew by 4.5% during the fourth quarter. Argonautica Private Wealth Management Inc. now owns 10,362 shares of the medical equipment provider's stock valued at $283,000 after acquiring an additional 449 shares during the period. Highland Capital Management LLC increased its stake in Smith & Nephew by 1.8% during the fourth quarter. Highland Capital Management LLC now owns 24,915 shares of the medical equipment provider's stock valued at $680,000 after acquiring an additional 450 shares during the period. Legacy Wealth Asset Management LLC raised its holdings in Smith & Nephew by 3.8% in the 3rd quarter. Legacy Wealth Asset Management LLC now owns 15,026 shares of the medical equipment provider's stock valued at $372,000 after acquiring an additional 546 shares in the last quarter. Finally, Allworth Financial LP lifted its position in shares of Smith & Nephew by 65.8% in the 4th quarter. Allworth Financial LP now owns 1,878 shares of the medical equipment provider's stock worth $51,000 after acquiring an additional 745 shares during the period. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Trading Up 2.6 %

Shares of SNN stock traded up $0.66 during trading hours on Tuesday, hitting $25.77. The company had a trading volume of 991,819 shares, compared to its average volume of 1,002,577. Smith & Nephew plc has a 12 month low of $21.52 and a 12 month high of $32.71. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. The firm's fifty day moving average is $25.33 and its 200 day moving average is $26.18.

Smith & Nephew Announces Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be issued a dividend of $0.462 per share. The ex-dividend date is Monday, April 1st. This represents a dividend yield of 2.8%.

Analyst Ratings Changes

Separately, StockNews.com lowered Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Monday. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy".

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.